Drugs / Tllsh2910
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03901638 | Apr 2019 → Apr 2023 | cerebellar ataxia, multiple system atrophy | National Taiwan University Hospital | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tllsh2910 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03901638 ↗ |
| Route | Oral | “Tllsh2910 80mg twice per day orally for 12 weeks” NCT03901638 ↗ |